Search
for
Sort by
Research 511–540 of 1000+
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Bioactivities, isolation and purification methods of polysaccharides from natural products: A review
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- The diagnosis and treatment of iron deficiency and its potential relationship to hair loss
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products
- Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases
- K <sub>ATP</sub> Channels and Cardiovascular Disease
- The Role of Vitamins and Minerals in Hair Loss: A Review
- Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
- Hormesis and medicine
- Extraskeletal actions of vitamin D
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Delivery and targeting of nanoparticles into hair follicles
- Extracellular Matrix Degradation Products and Low-Oxygen Conditions Enhance the Regenerative Potential of Perivascular Stem Cells
- Polycystic Ovary Syndrome
- Biocomposite nanofiber matrices to support ECM remodeling by human dermal progenitors and enhanced wound closure
- Dermatologic manifestations of endocrine disorders
- Diagnosis of hyperandrogenism: clinical criteria
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- Telogen effluvium
- Dermatology of androgen-related disorders
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- Targeting lymphoid-derived IL-17 signaling to delay skin aging
- The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Effect of physical stimuli on hair follicle deposition of clobetasol-loaded Lipid Nanocarriers